Atara Biotherapeutics
ATRA
$0.71
Share price
-0.30%
Change (1 day)
-66.29%
Change (1 year)
Categories
Atara Biotherapeutics (ATRA) - Cash on Hand
Cash on Hand as of December 2023 : $51.72 M
According to Atara Biotherapeutics's latest financial reports the company has $51.72 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Atara Biotherapeutics - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.24 B | -34.56% |
| 2021-12-31 | $0.37 B | -25.88% |
| 2020-12-31 | $0.50 B | 93.22% |
| 2019-12-31 | $0.25 B | -16.32% |
| 2018-12-31 | $0.30 B | 86.42% |
| 2017-12-31 | $0.16 B | -35.04% |
| 2016-12-31 | $0.25 B | -20.22% |
| 2015-12-31 | $0.32 B | 207.81% |
| 2014-12-31 | $0.10 B | 101.72% |
| 2013-12-31 | $51.61 M | 1126.88% |
| 2012-12-31 | $4.2 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ImmunoGen
IMGN | $0.60 B | 1,070.68% | 🇺🇸 USA |
 Agenus
AGEN | $76.11 M | 47.14% | 🇺🇸 USA |
 Affimed
AFMD | $80.59 M | 55.81% | 🇩🇪 Germany |